CD44 Glycosylation as a Therapeutic Target in Oncology.
Liao C, Wang Q, An J, Chen J, Li X, Long Q, Xiao L, Guan X, Liu J.
Liao C, et al. Among authors: guan x.
Front Oncol. 2022 Jul 21;12:883831. doi: 10.3389/fonc.2022.883831. eCollection 2022.
Front Oncol. 2022.
PMID: 35936713
Free PMC article.
Review.